Answers are grounded in this paper and cite their sources.
Purpose of review: The focus of this review is the role of hyaluronan in the cartilage extracellular matrix, the receptor-ligand binding of CD44 and hyaluronan, and subsequent responses by articular chondrocytes. Recent findings: The interaction of hyaluronan with two hyaladherins, aggrecan and CD44, has been more fully characterized recently, and the protein domains that support the high affinity protein-glycosaminoglycan binding have been identified. Transcriptional regulation conferring cartilage-specific expression of aggrecan has been elucidated and paralogous gene clusters of hyaladherins within chromosomes have been found. CD44 expression on articular chondrocytes includes a short tail variant that may function as a dominant negative receptor. Endocytosis by chondrocytes of hyaluronan in complex with proteolytic cleavage fragments of aggrecan supports a lysosomal-based mechanism for the turnover of these cartilage matrix components. Induction of a state of chondrocytic chondrocytes by small hyaluronan oligosaccharides as well as enhanced synthesis of aggrecan and hyaluronan provide evidence for signal transduction through the CD44 receptor on chondrocytes. Conversely, cartilage homeostasis is promoted by stable ligation of CD44 with endogenous high molecular weight hyaluronan, suggesting a biology to support patient therapy with intra-articular injections of hyaluronan. Summary: The influences of hyaluronan on matrix assembly and cell behavior continue to be explored in a variety of connective tissues. Definition of the pathways regulated by the interaction of hyaluronan, in a variety of molecular forms, with the CD44 receptor on articular chondrocytes, will be important for osteoarticular disease.
No takes yet. Share an insight, caveat, or question.
Knudson et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: